Some post-treatment biopsies exhibited mutations not detected in the pretreatment tumor, such as the ASXL1 alteration in patient 6 and the CCND1 alteration in patient 14 (Fig. 3a, Supplementary Data 1). This evidence concerns the gene CCND1 and neoplasm.